QYD-19077-35132
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 630 / MO
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Survey response — day 0, dose 1MedDRA: Headache — Feeling: Fair · Site: PainFree text: Slight headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Head discomfort — Feeling: Fair · Fever · HeadacheFree text: Slight headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-14
- 2021-03-17
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-30
- 2021-03-31
- 2021-04-02
- 2021-04-03
- 2021-04-05
- 2021-04-13
- 2021-04-21
- 2021-04-26
- 2021-05-05
- 2021-05-10
- 2021-09-29
-
2022-03-30
Survey response — 12 months, dose 2MedDRA: COVID-19, Medical counselling — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: I got omnicron · Healthcare visit (other): Car visitMedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-03-31
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Slight headache
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Slight headache
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SRO | Head discomfort | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release